Collaboration and License Agreements (Additional Information) (Details) - USD ($) $ in Millions		6 Months Ended	12 Months Ended
	Mar. 22, 2021	Jun. 30, 2024	Dec. 31, 2019	Mar. 04, 2024
License Agreement Terms [Member]
Related Party Transaction [Line Items]
Development milestone payment received			$ 3.0
Royalty Purchase Agreement [Member]
Related Party Transaction [Line Items]
Upfront payment received	$ 13.5
DOT-1 License Agreement [Member] | License Vosaroxin [Member]
Related Party Transaction [Line Items]
Regulatory, commercial milestones payments and double-digit royalty payments, receivable			57.0
DOT-1 License Agreement [Member] | License Agreement Terms [Member]
Related Party Transaction [Line Items]
Potential pre-commercialization payments receivable			$ 57.0
Day One Amendment [Member] | License Agreement Terms [Member]
Related Party Transaction [Line Items]
Regulatory, commercial milestones payments and double-digit royalty payments, receivable				$ 5.0
Milestone payments received		$ 5.0
Day One Amendment [Member] | Maximum [Member] | License Agreement Terms [Member]
Related Party Transaction [Line Items]
Regulatory, commercial milestones payments and double-digit royalty payments, receivable				$ 5.0